Corcept Therapeutics Inc. (NASDAQ: CORT) is one of the 10 best biotech stocks with highest upside potential.

Massachusetts’ biotech sector has been shedding jobs at a painful clip — but while some companies are cutting deep, one has spent more than $20 billion acquiring five of the state’s most promising ...

Following a turbulent year for the markets in general and biotech in particular, the industry made a notable recovery, ...

A biotechnology company has developed "what could turn out to be one of the most important cancer drugs in a generation," ...

Hemab Therapeutics Holdings Inc., a clinical-stage biotechnology company that counts Novo Nordisk Foundation as one of its biggest investors, raised $301.5 million in an upsized US initial public ...

Biopharma is rebounding across rare disease, oncology and neuroscience. Here, Cytokinetics achieved a rare milestone: a first ...

Teva Pharmaceutical Industries (NYSE: TEVA) will unveil its first-quarter results this Wednesday, April 29. Many Teva ...

State Street SPDR S&P Biotech ETF (XBI) gained +40.32% over the past year and equally weights roughly 145 stocks to provide exposure to smaller biotech companies. iShares Biotechnology ETF (IBB) ...

Young biotechs usually get acquired instead of profitably selling their own medicines. A growing number are proving they can, ...

Transaction Positions XTL at the Forefront of the Rapidly Expanding Global Psychedelic Therapeutics Market Following Major U.S. Regulatory ...

Angel investors are raising the bar with tighter criteria, backing strong teams, realistic markets and clear paths to exit ...